Uncover key drivers, emerging technologies, and competitive movements shaping the vaccine adjuvants market from 2025–2034 with trusted insights from The Business Research Company
What Is The Current Size And Expected Growth Outlook For The Vaccine Adjuvants Market?
The vaccine adjuvants market size has witnessed robust growth over recent years. It is anticipated to expand from $1.89 billion in 2024 to $2.01 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.6%. The market’s growth during the preceding period is attributable to factors such as a rise in vaccine development, the widespread presence of infectious diseases, governmental programs and immunization campaigns, increased research and development investments, and the global dissemination of vaccines.
The market size for vaccine adjuvants is projected to experience substantial expansion in the coming years. This market is predicted to reach $2.83 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.9%. The anticipated growth during this forecast period is primarily driven by factors such as pandemic preparedness, an expanding vaccine portfolio, global immunization objectives, increased collaborations and partnerships, and a heightened focus on therapeutic vaccines. Key trends expected over the forecast period encompass advancements in adjuvant technologies, an emphasis on enhancing immunogenicity, the utilization of combination adjuvants for improved effectiveness, a growing demand for safer and well-tolerated adjuvants, and the development of personalized vaccines and adjuvants.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp
Which Growth Drivers Are Propelling The Vaccine Adjuvants Market?
The increasing occurrence of infectious diseases is anticipated to propel the expansion of the vaccine adjuvants market in the forthcoming period. Infectious diseases are defined as conditions resulting from infections caused by viruses, bacteria, fungi, or parasites. Vaccines are utilized to combat these infectious diseases, which encompass hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For instance, according to the 2022 World Health Organization (WHO) report, approximately 10.6 million people globally were infected with tuberculosis in 2021, and 1.6 million succumbed to it. Furthermore, 1.5 million individuals acquired HIV in 2021, leading to 650,000 deaths. Thus, the escalating prevalence of infectious diseases is set to drive the vaccine adjuvants market.
Which Segmentation Factors Are Most Significant In The Vaccine Adjuvants Market Analysis?
The vaccine adjuvants market covered in this report is segmented –
1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases
Subsegments:
1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions
2) By Pathogen Components: Bacterial Components, Viral Components
3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles
4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems
5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants
What New Opportunities Are Emerging From Trends In The Vaccine Adjuvants Market?
Product innovations represent a significant trend gaining traction within the vaccine adjuvants market. Companies active in the vaccine adjuvants market are prioritizing the adoption of inventive solutions to bolster their competitive standing. As an illustration, in December 2022, Evonik Industries, a Germany-based chemical manufacturing company, launched PhytoSquene, a squalene derived from plants, specifically amaranth oil. This environmentally friendly substitute for traditional shark-derived squalene is intended for deployment in vaccine adjuvants and other pharmaceutical contexts, improving vaccine efficacy through the potentiation of immune responses. The introduction of PhytoSquene accentuates the increasing focus on sustainability across the pharmaceutical sector.
Who Are The Most Influential Companies In The Vaccine Adjuvants Market?
Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report
Which Region Holds The Largest Share In The Vaccine Adjuvants Market Today?
North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp
Browse Through More Reports Similar to the Global Vaccine Adjuvants Market 2025, By The Business Research Company
Chemicals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report
Ethylene Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ethylene-global-market-report
Genetically Modified Crops Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
